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Microparticles are released from the endothelium under normal 
homeostatic conditions and have been shown elevated in disease 
states, most notably those characterised by endothelial dysfunction. 
The endothelium is sensitive to oxidative stress/status and vascular 
cell  adhesion  molecule-1  (VCAM-1)  expression  is  upregulated 
upon activated endothelium, furthermore the presence of VCAM-1 
on microparticles is known. S100A12, a calcium binding protein 
part  of  the  S100  family,  is  shown  to  be  present  on  circulating 
leukocytes and is thought a sensitive marker to local inflammatory 
process, which may be driven by oxidative stress. Eight healthy 
males were subjected to breathing hypoxic air (15% O2, approxi-
mately equivalent to 3000 metres altitude) for 80 minutes in a 
temperature controlled laboratory and venous blood samples were 
processed immediately for VCAM-1 microparticles (VCAM-1 MP) 
and S100A12 association with leukocytes by flow cytometry. A 
pre-hypoxic blood sample was used for comparison. Both VCAM-1 
MP and S100A12 association with neutrophils were significantly 
elevated post hypoxic breathing later declining to levels observed in 
the pre-test samples. A similar trend was observed in both cases and 
a correlation may exist between these two markers in response to 
hypoxia. These data offer evidence using novel markers of endothe-
lial and circulating blood responses to hypoxia.
Introduction
During periods of hypoxia, cells are metabolically compromised 
resulting in cellular dysfunction that can eventually lead to cell death 
through  metabolic  failure.  Neutrophils  bound  to  the  endothelial 
surface  accelerate  endothelial  cell  dysfunction  and  tissue  destruc-
tion  through  a  variety  of  cytotoxic  mechanisms.  In  addition  to 
physically  plugging  capillaries,1  activated  neutrophils  mediate  a 
variety of harmful responses, such as production of reactive oxygen 
species  (ROS),  cytotoxic  enzymes  and  cytokines.2  Many  of  these 
also  recruit  additional  neutrophils  and  enhance  their  adhesive-
ness to the vascular endothelium. The attachment of neutrophils 
to the vascular endothelium is mediated by adhesion glycoprotein 
complexes expressed both on the surface of the neutrophil and on 
the surface of the endothelial cell. ROS, in large quantities, disrupt 
the redox balance of cells resulting in oxidative stress and damage to 
membrane structures (possibly leading to membrane microparticle 
release), protein damage and cause the activation of signal transduc-
tion pathways that lead to apoptosis.3
Microparticles (MP) are cell membrane fragments released into 
the circulation to a certain extent in healthy individuals under normal 
homeostatic conditions4 and release is increased under stress condi-
tions and disease. MP are released through either cellular activation 
or apoptosis.5 We recently observed a correlation between vascular 
cell  adhesion  molecule-1  (VCAM-1)  positive  MP  (VCAM+  MP) 
released from the endothelium and oxidant status,6 as measured by 
thiobarbituric acid reactive substances (TBARS), which is a measure 
of  lipid  peroxidation.  Previous  to  this  observation,  a  circadian 
rhythm in VCAM+ MP was observed in healthy males, that along 
with additional data acquired within this group allowed a normal 
homoeostatic range to be established.7
VCAM-1  is  an  adhesion  molecule,  expressed  on  activated 
endothelium,  being  involved  in  leukocyte  attachment  and  trans-
migration  and  is  a  therapeutic  target  in  inflammatory  disease.8 
Endothelial MP offer an insight into the state of the endothelium as 
they carry surface antigens particular to the cell of origin and further-
more these MP can be routinely analysed with specific antibodies by 
flow cytometry.5,9 The endothelium is sensitive to oxidative stress10 
and produces nitric oxide (NO) via induction of inducible nitric 
oxide synthase (iNOS) and constitutively expressed endothelial nitric 
oxide synthase (eNOS). The endothelium may become activated in 
times of oxidative stress and this can result in cellular remodelling 
and the release of MP.11 Diseases, particularly those characterised by 
endothelial dysfunction, have been shown to result in an elevated 
concentration of endothelial derived MP.5
S100A12,  a  calcium  binding  protein  belonging  to  the  S100 
family, acts as a ligand for the multiligand cell surface receptor for 
advanced  glycation  end  products  (RAGE)12  and  soluble  RAGE 
(sRAGE). S100 proteins have been implicated in intracellular and 
extracellular regulatory processes and been shown to mediate inflam-
matory responses.13 S100A12 is secreted by activated neutrophils 
and inflamed tissue.14 S100A12 has been shown to interact with 
RAGE  present  on  the  endothelium  to  trigger  an  activated  state 
(through NFκB pathway) resulting in induction of VCAM-1 and 
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enhanced expression of intercellular adhesion 
molecule-1 (ICAM-1) in HUVECS that can 
aid in further recruitment of leukocytes to the 
injured endothelial cells.12
The  aim  of  this  study  was  to  quantify 
the  effects  of  oxidative  stress,  induced  by 
breathing  air  equivalent  to  approximately 
3,000  metres  (m)  altitude  (15%  oxygen)15 
on  circulating  VCAM+  MP  concentration, 
thus  gaining  an  insight  into  the  endothe-
lial response to hypoxia and furthermore to 
correlate  this  response  with  a  novel  stress 
marker, S100A12, associated with the circu-
lating  blood  cell  population  of  neutrophils 
and monocytes.
Results
Venous  blood  samples  were  taken  on 
numerous days, prior to the hypoxic breathing, 
to establish a normal range of values in healthy 
male subjects over a 24 hour (h) period. This 
data was added to our previously published 
data  that  demonstrated  a  circadian  rhythm 
and  resulted  in  an  overall  mean  of  1350 
VCAM+ MP per microlitre (μL) of platelet 
poor plasma (PPP), with a mean coefficient of variation of 44% (n = 
190). VCAM+ MP levels are higher in the morning hours, reaching 
a minima late afternoon and again in the night. For this reason, the 
hypoxic  (15%  Oxygen)  treatment  was  scheduled  for  09:00,  after 
which a decrease in VCAM+ MP is normally observed. There was a 
significant effect for time (F = 11.9; p < 0.001) for VCAM+ MP (Fig. 
1), where post-hypoxic breathing (11:00), there was a large increase 
from 1020 ± 263 to 3600 ± 1040 per μL PPP (p = 0.001), a value 
well outside the established normal range. Thereafter, VCAM+ MP 
decreased towards the normal range, but at 14:00 was still signifi-
cantly higher than at 08:00 (p = 0.010). After this time no significant 
changes were observed in relation to the pre-test value.
There was a significant effect for time (F = 7.3; p < 0.001) for 
TBARS (Fig. 1), where TBARS demonstrated a small non-significant 
increase from 08:00 to 14:00, and thereafter, a marked downward 
trend.  TBARS  at  20:00  was  significantly  lower  than  at  11:00   
(p = 0.013) and 14:00 (p = 0.029) and significantly lower at 17:00 
than 14:00 (p = 0.047).
S100A12 association with monocytes (S100A12mono) and neutro-
phils  (S100A12neutro)  was  assessed  by  flow  cytometry.  Typical 
forward  scatter/side  scatter  and  fluorescent  antibody  labelling  of 
neutrophils and monocytes is shown in Figure 2. There was a signifi-
cant effect for time for S100A12neutro (F = 9.1; p < 0.001) (Fig. 3), 
where a marked increase was observed immediately after hypoxic 
breathing (p < 0.001). The S100A12neutro remained elevated at 14:00   
(p = 0.044). The effect of time on S100A12mono (Fig. 3) was not 
statistically significant (F = 1.3; p = 0.29).
Figure 1. Time dependent profile for VCAM+ MP and TBARS before and after hypoxic breathing. The 
data are represented as the mean and standard error of the mean (n = 8). HB = time during which 
subjects breathed hypoxic air.
Figure  2.  Typical  flow  cytometry  profiles  showing  (top)  forward  scatter/
side scatter with Netrophils and monocytes gated accordingly and (bottom) 
fluorescence profiles showing gated (black) neutrophils and (grey) monocytes 
incubated with either (filled) goat serum or (line) anti-human EN-RAGE.Hypoxic microparticle release
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expression.19  Increased  serum  concentrations  of 
S100A12 have been shown in patients with severe 
bacterial infections.20 Furthermore, serum S100A12 
maybe of use as a diagnostic marker in inflammatory 
bowel disease,21 arthritis22 and asthma.23 In inflam-
matory disease high concentrations of S100A12 have 
also been shown at local sites of inflammation such 
as  synovial  fluid,24  inflamed  bowel  mucosa25  and 
atherosclerotic lesions.26
S100A12  interaction  with  RAGE  is  capable  of 
  activation  of  endothelial,  lymphocyte  and   
macrophage  cells  directly.13  S100A12  has  been 
postulated  to  be  a  novel  marker  of  localised   
inflammatory  processes  in  part  due  to  its   
overexpression  at  local  inflammatory  sites.19  As 
S100A12 is a ligand for RAGE it may be postulated 
that there is either an increase in RAGE expression 
upon  the  neutrophil  surface  following  hypoxia  or 
a  higher  degree  of  circulating  S100A12  is  bound 
to  the  receptor.  RAGE  expression  has  previously 
been shown to be affected by hypoxia via hypoxia-
inducible factor-1.27 Interaction between RAGE and 
its ligands has also been demonstrated to upregulate 
VCAM-1 expression on endothelium and promote 
other  proinflammatory  pathways.28  Furthermore 
endothelial  cells  release  RAGE  specific  ligands  in 
response to hypoxia,29 which could account for the observed increase 
of neutrophil associated S100A12.
The amount of S100A12 associated with both neutrophils and 
monocytes  appear  correlated  in  this  study,  suggesting  a  similar   
response  to  hypoxia,  although  the  increase  in  the  S100A12mono 
subject mean was not found significant. The increase in S100A12neutro 
following  hypoxic  breathing  suggests  S100A12  may  also  be  a 
marker of oxidative stress in the circulating blood cell population. 
A significant correlation was observed between both endothelium 
and neutrophil reaction to hypoxia via release of VCAM+ MP and 
S100A12neutro, (p = 0.044). This may be expected as both cell types 
have  intrinsic  roles  in  hypoxia  (especially  I/R  injury)  and  loca-
lised inflammation, where VCAM-1 mediates firm attachment of 
neutrophils to the endothelium. A recent study found significant 
correlations  between  serum  concentrations  of  advanced  glycation 
products (AGE) and VCAM-1 and the soluble form of S100A12 in 
diabetic patients.30 It has already been suggested that serum levels of 
cell surface markers may in fact be MP associated and not entirely 
freely  soluble,5  furthermore  elevated  endothelial  MP  concentra-
tion is established in diabetes.31 Therefore these data30 may well 
include VCAM+ MP released from dysfunctional endothelium in 
diabetic patients and their correlation with S100A12, as observed in 
the present study. In addition advanced oxidation protein products 
have recently been shown to induce overexpression of VCAM-1 on 
endothelial cells via S100A12 mediated signalling.32,33 Induction of 
ROS generation and VCAM-1 expression was effectively prevented 
by blocking S100A12 binding to the endothelial surface.32
The effects of hypoxia on the vasculature are well characterised 
and  here  we  highlight  two  potentially  novel  markers  which  link 
the blood response and endothelial response within healthy human 
subjects. Further research is necessary to elucidate the specific cellular 
mechanism and consequences behind these observations.
Figure 3. Time dependent profile for S100A12 expression on monocytes and neutrophils 
before and after hypoxic breathing. The data are represented as the mean and standard error 
of the mean (n = 8). HB = time during which subjects breathed hypoxic air.
Significant relationships were observed between VCAM+ MP and 
S100A12neutro (rs = 0.39; p = 0.044) and between S100A12mono and 
S100A12neutro (rs =0.74; p < 0.001).
Discussion
Endothelial MP have been proposed as a sensitive blood borne 
marker  of  endothelial  state.4  The  endothelium  is  known  to  be 
affected  by  oxidative  stress  and  the  subjects  in  this  study  were 
exposed to a significant oxidative stress by hypoxic breathing and 
subsequent re-oxygenation. This resulted in an increase in plasma 
TBARS, a measure of lipid peroxidation, and a marker of oxida-
tive stress. Hypoxia leads to numerous cellular responses including 
generation of ROS and production of hypoxia-inducible factor-1.16 
Hypoxic breathing led to a significant increase in circulating VCAM+ 
MP (Fig. 1), demonstrating a novel measure of endothelial response 
to hypoxia. Whether or not these MP came from localised activated 
endothelium or hypoxia mediated endothelial activation is debat-
able. Previously we have reported a circadian variation in VCAM+ 
MP,7  with  an  early  morning  peak  decreasing  into  the  afternoon. 
Conversely, the data presented here shows a large increase from early 
morning, after hypoxic breathing to levels well outside the normal 
range.
The synthesis of S100A12 by neutrophil granulocytes has been 
shown.17 The role of S100A12 has been implicated in the innate 
immune  system  in  response  to  infection.  The  exact  nature  of 
S100A12 ligand interaction is unclear, it has been shown able to 
bind both itself and a range of other molecules and was suggested 
to act as a molecular chaperone in the presence of calcium.18 RAGE 
been identified as a receptor for S100A12.12 This RAGE interac-
tion leads to initiation of pro-inflammatory signalling cascades via 
MAP-Kinase and NFκB, resulting in increased adhesion molecule Hypoxic microparticle release
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TBARS  analysis.  EDTA  plasma  was  obtained  via  centrifuga-
tion  of  the  EDTA  Vacuette®  (10  min,  1500  xg)  and  stored  at 
-80°Centigrade until analysed. Plasma TBARS was then analysed 
using a commercially available kit (Zeptometrix) following manufac-
turers’ instructions and are expressed as malondialdeyde equivalents.
Statistical analysis. All statistical analyses were completed using 
SPSS for Windows version 16.0 (SPSS Inc., Chicago, IL). Normality 
for each dependent variable for each time point was checked using 
Q-Q plots and deemed plausible in each instance. Sample descriptive 
statistics are reported as means and standard deviations. The effect of 
time on TBARS expression and S100A12 expression on both mono-
cytes (S100A12mono) and neutrophils (S100A12neutro) was analyzed 
using  one-way  analysis  of  variance  for  repeated  measures.  The 
Huynh-Feldt corrected p value was reported where the sphericity 
assumption was violated (as identified by a significant Mauchly’s test 
statistic). The VCAM+ MP data showed considerably less variance at 
08:00 in comparison with later time points. The VCAM+ MP data 
was therefore analyzed using a linear mixed model incorporating an 
autoregressive repeated covariance structure. Sidak post hoc pairwise 
comparisons were used in the event of significant main effects. The 
relationship between VCAM+ MP and S100A12neutro and between 
S100A12mono and S100A12neutro were analyzed using the Spearman 
correlation.  Two-tailed  statistical  significance  was  as  accepted  as   
p < 0.05.
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